AK Medical Holdings (1789.HK) Earnings Analysis

AK Medical Holdings (1789.HK) next reports earnings on 2026-09-02, consensus EPS 0.1963 HKD. Last quarter (2026-03-25) it beat with EPS 0.1781 HKD vs 0.1669 HKD est (+6.7%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E 16.12.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 1789.HK next report earnings?

Next earnings date2026-09-02
Consensus EPS estimate0.1963 HKD
Revenue estimate0.89B

1789.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-250.1781 HKD0.1669 HKD+6.7%Beat
2025-08-270.1534 HKD0.1534 HKD0%Beat
2024-08-280.1348 HKD0.1289 HKD+4.6%Beat

Beat rate: 3/3 (100%) over reported quarters with consensus data.

1789.HK valuation and analyst view

Trailing P/E16.12
Trailing EPS0.30335 HKD
Price / book1.85
Dividend yield2.10%
Market cap6.18B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is AK Medical Holdings (1789.HK)'s next earnings date?

AK Medical Holdings is next scheduled to report on 2026-09-02, with a consensus EPS estimate of 0.1963 HKD and revenue estimate of 0.89B.

Did 1789.HK beat earnings last quarter?

In its 2026-03-25 report, 1789.HK posted EPS of 0.1781 HKD versus a 0.1669 HKD estimate — a beat of 6.7%.

What is 1789.HK's earnings track record?

Over the last 3 reported quarters with consensus data, 1789.HK beat estimates 3 times (100%).

What is 1789.HK's current P/E ratio and EPS?

1789.HK trades at a trailing P/E of 16.12 on trailing EPS of 0.30334989834686704 HKD.

What do analysts rate 1789.HK?

1789.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.